Basic Information
Calliditas Therapeutics is a specialty pharmaceutical company that develops medicines in areas of unmet medical need. Its products include Nefecon (a drug for treating IgA nephropathy) and Busulipo (an alternative for bone marrow ablation prior to bone marrow transplantation). The company was founded in 1991 and is headquartered in Stockholm, Sweden.
Calliditas Therapeutics AB
Stockholm,Stockholm,Sweden
51~100 people
January 01, 1991
johan.haggblad@pharmalink.se
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios